Translate this page to:
In JoVE (1)
Other Publications (9)
Articles by Andrew Harrison in JoVE
Induction of Adhesion-dependent Signals Using Low-intensity Ultrasound
James Roper1, Andrew Harrison2, Mark D. Bass1
1School of Biochemistry, University of Bristol, 2Smith and Nephew
This protocol describes the stimulation of cultured fibroblasts with low-intensity pulsed ultrasound, which drives focal adhesion formation and Rac1 activation by mimicking engagement of the transmembrane matrix receptor, syndecan-4. This approach allows investigation of a successful clinical technique at the cellular level, thereby providing opportunities for refinement of the therapy.
Other articles by Andrew Harrison on PubMed
The Deleted in Colorectal Carcinoma (DCC) Gene 201 R --> G Polymorphism: No Evidence for Genetic Association with Autoimmune Disease
European Journal of Human Genetics : EJHG. Nov, 2003 | Pubmed ID: 14571268
The product of the deleted in colorectal carcinoma (DCC) gene has a role in apoptosis and is a positional candidate for IDDM6, the putative chromosome 18q12-q23 autoimmune disease locus. We hypothesised that a nonconservative substitution (DCC 201 R --> G; nucleotide (nt) 601 C --> G), located in an extracellular immunoglobulin-like domain of DCC, is an aetiological determinant of autoimmunity. We tested this hypothesis by genetically testing the nt 601 C --> G polymorphism for association with three autoimmune phenotypes in a large population-based case-control study. There was no evidence for association of DCC nt 601 C --> G with autoimmune disease in cohorts comprising 2253 subjects with rheumatoid arthritis, type I diabetes and Graves' disease, and 2225 control subjects, from New Zealand and the United Kingdom. Furthermore, using the transmission disequilibrium test, there was no significant evidence for biased transmission of the nt 601 C --> G polymorphism to probands within a 382 family type I diabetes affected sibpair cohort from the United Kingdom. Thus, the DCC 201 R --> G polymorphism does not appreciably influence risk of developing the autoimmune diseases tested.
Only One Independent Genetic Association with Rheumatoid Arthritis Within the KIAA1109-TENR-IL2-IL21 Locus in Caucasian Sample Sets: Confirmation of Association of Rs6822844 with Rheumatoid Arthritis at a Genome-wide Level of Significance
Arthritis Research & Therapy. 2010 | Pubmed ID: 20553587
The single nucleotide polymorphism (SNP) rs6822844 within the KIAA1109-TENR-IL2-IL21 gene cluster has been associated with rheumatoid arthritis (RA). Other variants within this cluster, including rs17388568 that is not in linkage disequilibrium (LD) with rs6822844, and rs907715 that is in moderate LD with rs6822844 and rs17388568, have been associated with a number of autoimmune phenotypes, including type 1 diabetes (T1D). Here we aimed to: one, confirm at a genome-wide level of significance association of rs6822844 with RA and, two, evaluate whether or not there were effects independent of rs6822844 on RA at the KIAA1109-TENR-IL2-IL21 locus.
A Strong Role for the ABCG2 Gene in Susceptibility to Gout in New Zealand Pacific Island and Caucasian, but Not Māori, Case and Control Sample Sets
Human Molecular Genetics. Dec, 2010 | Pubmed ID: 20858603
Genetic variation in ABCG2 (rs2231142, Q141K), encoding a uric acid transporter, is associated with gout in diverse populations. The aim of this study was to examine a role for ABCG2 in gout susceptibility in New Zealand Māori, Pacific Island and Caucasian samples. Patients (n = 185, 173 and 214, for Māori, Pacific Island and Caucasian, respectively) satisfied the American College of Rheumatology gout classification criteria. The comparison samples comprised 284, 129 and 562 individuals, respectively, without gout. rs2231142 was genotyped and stratification accounted for using genomic control markers. Association of the minor allele of rs2231142 with gout was observed in the Pacific Island samples (OR = 2.80, P(STRAT) < 0.001 after accounting for effects of population structure), but not in the Māori samples (OR = 1.08, P(STRAT)= 0.70), with heterogeneity in association evident between the Māori and Pacific Island datasets (P(HET) = 0.001). A similar dichotomy in association was observed when samples were stratified into Western (Tonga, Samoa, Niue, Tokelau) versus Eastern Polynesian (Māori, Cook Island) origin (OR = 2.59, P(STRAT) < 0.001; OR = 1.12, P(STRAT)= 0.48, respectively; P(HET) = 0.005). Association with gout was observed in the Caucasian samples (OR = 2.20, P = 3.2 × 10(-8)). Unlike SLC2A9, which is a strong risk factor for gout in both Māori and Pacific Island people, ABCG2 rs2231142 has a strong effect only in people of Western Polynesian ancestry. Our results emphasize the need to account for sub-population differences when undertaking biomedical genetic research in a group defined by a geographical region and shared ancestry but characterized by migratory events that create bottlenecks and altered genetic structure in the founder populations.
The PTPN22 Locus and Rheumatoid Arthritis: No Evidence for an Effect on Risk Independent of Arg620Trp
PloS One. 2010 | Pubmed ID: 20975833
The Trp(620) allotype of PTPN22 confers susceptibility to rheumatoid arthritis (RA) and certain other classical autoimmune diseases. There has been a report of other variants within the PTPN22 locus that alter risk of RA; protective haplotype '5', haplotype group '6-10' and susceptibility haplotype '4', suggesting the possibility of other PTPN22 variants involved in the pathogenesis of RA independent of R620W (rs2476601). Our aim was to further investigate this possibility.
Analysis of Association of DNASE2 Promoter Variation with Rheumatoid Arthritis in European Caucasians
Annals of the Rheumatic Diseases. Aug, 2011 | Pubmed ID: 21317435
The SLC2A9 Nonsynonymous Arg265His Variant and Gout: Evidence for a Population-specific Effect on Severity
Arthritis Research & Therapy. 2011 | Pubmed ID: 21658257
The C allele of the nonsynonymous Arg265His (rs3733591) variant of SLC2A9 confers risk for gout in Han Chinese, Solomon Island and Japanese samples, with a stronger role in tophaceous gout. There is no evidence for an association with gout in Caucasian populations. In the present study, we tested rs3733591 for association with gout in New Zealand (NZ) Māori, Pacific Island and Caucasian samples.
No Evidence for Association of Chr 9p21 Variant Rs1333049 with Gout in New Zealand Case-control Sample Sets
Rheumatology (Oxford, England). Mar, 2012 | Pubmed ID: 22396608
Arthritis Research & Therapy. Apr, 2012 | Pubmed ID: 22541845
Two major gout-causing genes have been identified, the urate transport genes SLC2A9 and ABCG2. Variation within the SLC17A1 locus, which encodes sodium-dependent phosphate transporter 1, a renal transporter of uric acid, has also been associated with serum urate concentration. However, evidence for association with gout is equivocal. We investigated the association of the SLC17A1 locus with gout in New Zealand sample sets.
Replication of Association of the Interleukin 23 Receptor Rs1343151 Variant with Rheumatoid Arthritis in Caucasian Sample Sets
Annals of the Rheumatic Diseases. Jan, 2012 | Pubmed ID: 21926184